Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group-Reference-Cited by-同舟云学术

Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group

Published:2012-02-06 Issue:7 Volume:26 Page:1730-1741
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Westers T M,Ireland R,Kern W,Alhan C,Balleisen J S,Bettelheim P,Burbury K,Cullen M,Cutler J A,Della Porta M G,Dräger A M,Feuillard J,Font P,Germing U,Haase D,Johansson U,Kordasti S,Loken M R,Malcovati L,te Marvelde J G,Matarraz S,Milne T,Moshaver B,Mufti G J,Ogata K,Orfao A,Porwit A,Psarra K,Richards S J,Subirá D,Tindell V,Vallespi T,Valent P,van der Velden V H J,de Witte T M,Wells D A,Zettl F,Béné M C,van de Loosdrecht A A

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu201230.pdf

Reference66 articles.

1. Cazzola M, la Porta MG, Travaglino E, Malcovati L . Classification and prognostic evaluation of myelodysplastic syndromes. Semin Oncol 2011; 38: 627–634.

2. Valent P, Horny HP, Bennett JM, Fonatsch C, Germing U, Greenberg P et al. Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: consensus statements and report from a working conference. Leuk Res 2007; 31: 727–736.

3. Ogata K, Nakamura K, Yokose N, Tamura H, Tachibana M, Taniguchi O et al. Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome. Blood 2002; 100: 3887–3896.

4. Wells DA, Benesch M, Loken MR, Vallejo C, Myerson D, Leisenring WM et al. Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation. Blood 2003; 102: 394–403.

5. van de Loosdrecht AA, Westers TM, Westra AH, Drager AM, van der Velden VHJ, Ossenkoppele GJ . Identification of distinct prognostic subgroups in low- and intermediate-1-risk myelodysplastic syndromes by flow cytometry. Blood 2008; 111: 1067–1077.

Cited by 208 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Childhood Myelodysplastic Syndromes (MDSs);Pediatric Pathology of Hematopoietic and Histiocytic Disorders;2024-02-15

2. Determinants of lenalidomide response with or without erythropoiesis-stimulating agents in myelodysplastic syndromes: the HOVON89 trial;Leukemia;2024-01-31

3. Aberrant myelomonocytic CD56 expression predicts response to cyclosporine therapy in pediatric patients with moderate aplastic anemia;Frontiers in Pediatrics;2023-12-12

4. Childhood Myelodysplastic Syndrome;Clinics in Laboratory Medicine;2023-12

5. Flow Cytometric Assessment of Myelodysplastic Syndromes/Neoplasms;Clinics in Laboratory Medicine;2023-12